U.S. Brand Name
Odefsey
Abbreviation(s)
FTC/RPV/TAF
First U.S. Approval
NRTI Based?
No
One Dose Daily?
Yes
Single Tablet Regimen
Yes
U.S. FDA Label
U.S. Manufacturer
Formulations
| Strength | Formulation | Image | Description | Boosted |
|---|---|---|---|---|
|
FTC 200 mg, RPV 25 mg, TAF 25 mg
|
Film-Coated Tablets
|
|
Gray, capsule-shaped, film-coated tablets debossed with "GSI" on one side and "255" on the other side.
|
No
|
Adult dosing
| Dosage | Formulation |
|---|---|
|
1 tablet daily
|
Film-Coated Tablets
|
Pediatric dosing
References
Assistance Programs
